focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.50
Bid: 227.00
Ask: 228.00
Change: 1.50 (0.66%)
Spread: 1.00 (0.441%)
Open: 225.00
High: 229.50
Low: 224.00
Prev. Close: 226.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling

Tue, 16th Apr 2024 21:57

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value was 39.7 pence per share at February 29, down from 45.3 pence at February 28, 2023. Chair says: "In a year when the FTSE AIM All Share Index declined by 14%, your company made a loss of GBP1.75 million with net assets down by 19%" and that this year's results "can only be described as disappointing". Declares 55.0p dividend for the year to February 29, unchanged from the year before. Says it now has "the critical mass we have been seeking for a long time", and that it is currently seeking alternative plans to manage its rump portfolio once its primary assets have been realised.

----------

Petra Diamonds Ltd - Bermuda-based diamond mining group - Says revenue for the third quarter of financial 2024 totalled USD66 million, down from USD90 million in the second quarter. Says the decrease was due to lower production and the timing of receipts from Tender 5. Says this fifth tender cycle yielded USD49 million from the sale of 362,132 carats at an average price of USD136 per carat. This compares with USD48 million from 428,860 carats at USD112 per carat in the fourth tender cycle. Says production for the quarter was consistent with the preceding three months and in line with expectations. Total tonnes treated decreased 1.5% to 2.9 million tonnes from 3.0 million tonnes.

----------

J Smart & Co (Contractors) PLC - Edinburgh-based construction contractor - Pretax profit for the six months to January 31 falls 21% to GBP205,000 from GBP260,000 the year before. Revenue however rises 54% to GBP8.6 million from GBP5.6 million. Company declares 0.96p per share interim dividend, unchanged year-on-year. Cost of sales rises to GBP6.4 million from GBP2.1 million. Company says construction material prices "are still rising, which continues to affect the viability of all types of potential projects". Says there has been a "slight improvement" on limited reservations compared to in late 2023, but continuing economic issues are still affecting consumer sentiment. Says lettings remain "robust" but that in the year to July 31 "there will definitely be profit erosion due to lack of external contracts, the lack of recovery of overhead costs, the continued increase in material costs, prolonged programmes due to utility infrastructure and statutory authority delays and the cost of holding private housing stock".

----------

Tertiary Minerals PLC - mineral development company focused on deposits in the US, Zambia and Northern Europe - Announces that drilling is now underway at the Konkola West Copper Project in Zambia. The project "is targeting projected deep down-dip and along-strike extensions of the contiguous Lubambe-Mingomba-Konkola copper deposits to the east of the licence and which extend north into the Musoshi mining complex in the Democratic Republic of the Congo". The long continuous zone of mineralisation is 15 kilometres total and contained a pre-mining endowment of over 775 million tonnes of copper graded at between 2% and 3%.

----------

PureTech Health PLC - London-based biotherapeutics company - Completes enrolment in the Elevate IPF Phase 2b clinical trial, which will evaluate LYT-100 or deupirfenidone in patients with idiopathic pulmonary fibrosis or IPF. Says LYT-100 is a deuterated form of pirfenidone, one of the two standard-of-care treatments approved to treat IPF. The randomised double-blind trial will measure as primary endpoint the rate of decline in forced vital capacity for the combined LYT-100 arms versus the placebo group over 26 weeks. Says other key endpoints will include tolerability measures, biomarkers and patient-reported outcomes. Expects topline results in the fourth quarter of 2024.

----------

DP Poland PLC - London-based operator of Domino's pizza stores and restaurants in Poland and Croatia - Raises gross GBP1 million pursuant to oversubscribed retail offer, with 10.1 million shares to be issued as a result. Says it has raised around GBP20.5 million in total from subscription, placing and retail offer combined. Fundraise was announced in late March, with placing price of 9.92p per share. This included a GBP11 million investment from Domino's Pizza Group PLC.

----------

Golden Metal Resources PLC - Nevada-focused metals exploration company - Says ground magnetic survey has detected significant anomalies at its Garfield project in Nevada's Walker Lane Mineral Belt. Says two magnetic anomalies were detected within the 'High-Grade' zone, and another was located in the southwestern part of the 'Power-Line' zone. Says it is "very encouraged" by the results, and has commissioned a ground magnetic geophysics survey across some of the main target areas at Pilot Mountain. Results are currently being processed. Adds that drilling preparations for Pilot Mountain are "well underway" and expects to receive permits "imminently". Chief Executive Officer Oliver Friesen says 2024 "is shaping up to be a very exciting year for Golden Metal", which is "positioned perfectly to address" the increasing demand for "important metals such as tungsten".

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more
11 Jul 2022 19:15

TRADING UPDATES: BlueRock hit by extreme weather; Harbour drills well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2022 21:50

IN BRIEF: PureTech Health begins pulmonary fibrosis study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Begins late-stage clinical study of its wholly-owned candidate LYT-100, or deupirfenidone, in idiopathic pulmonary fibrosis. Will evaluate efficacy of two doses, as well as relative tolerability and efficacy with pirfenidone. IPF is a chronic condition causing progressive scarring of the lungs, which currently has a poor prognosis. Also advances LYT-200 programme through clinical development, and plans to begin leukemia study by the end of 2022.

Read more
28 Jun 2022 14:45

IN BRIEF: PureTech Health's founded firm Vedanta launches new facility

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Announces that its founded firm Entity Vedanta Biosciences Inc launches a new manufacturing facility. The facility will "provide clinical and commercial supply of oral therapies" for people infected with a diarrhoea-causing bacteria, firm says.

Read more
21 Jun 2022 14:24

IN BRIEF: PureTech Health's Gelesis wins USD15 million Plenity order

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another USD15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to USD55 million, out of which USD45 million was ordered in the last 12 months, PureTech Health adds.

Read more
14 Jun 2022 16:54

IN BRIEF: PureTech achieves availability milestone for LYT-300 study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Announces results from phase two study of LYT-100-COV on patients with post acute or long Covid with respiratory complications.

Read more
14 Jun 2022 07:33

PureTech reports 'Glyph' milestone, disappointing long Covid results

(Sharecast News) - PureTech Health said on Tuesday that it had met a milestone in proving its 'Glyph' therapeutic platform, while separately announcing disappointing results from a study into long Covid.

Read more
1 Jun 2022 18:21

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review.

Read more
25 May 2022 10:18

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday.

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 11:18

IN BRIEF: PureTech shares rise as unveils USD50 million share buyback

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Approves share buyback of up to USD50 million. Programme follows "follows consultation with shareholders and is consistent with PureTech's capital allocation strategy and stated approach to drive additional value for its shareholders," company says. PureTech says it had USD413.2 million of net cash and cash equivalents at March 31. Given size of balance sheet, PureTech is confident it can return capital to shareholders and also maintain "sufficient cash on hand to deliver" on strategic priorities.

Read more
5 May 2022 10:09

PureTech to buy back up to $50m of shares

(Sharecast News) - PureTech Health has announced a $50m share buyback programme, sending shares in the FTSE 250 biotech sharply higher.

Read more
4 May 2022 13:35

PureTech entity Gelesis reports positive data for weight loss drug

(Alliance News) - Boston-based biotechnology company PureTech Health PLC's founded entity Gelesis Holdings Inc said on Wednesday that its weight loss drug showed positive responses in adults in clinical trials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.